Nasjonal oversikt over covid-19-studier

Basert på innsamlede opplysninger fra helseregionene og deres underliggende miljøer vil det kontinuerlig oppdateres en nasjonal oversikt over covid-19-studier.

Nye studier meldes via questback.

Oversikten viser registrerte forskningsprosjekter (startet/planlagt) i spesialisthelsetjenesten som gjelder covid-19 pasienter. Oversikten er delt inn i 3 tabeller; behandlingsstudier, observasjonsstudier og andre.

I perioden etter registreringen vil trolig flere prosjektledere innlemme nye samarbeidspartnere og prosjektet endre status fra planlagt til pågående. For at listen til enhver tid skal være oppdatert ber vi om at prosjektledere melder slike endringer i e-post til Siv.Morkved@helse-midt.no med kopi til Maria.Garli.Hegvik@stolav.no. Ukentlige oppdateringer, fortrinnsvis fredager.

Først publisert: 03.04.2020
Sist oppdatert: 29.05.2020
Antall nye studier: 5
Totalt antall studier: 98

Study design: Treatment

NrProject status Project leader/Contact info
Health trust/InstitutionStudy title/Aims of the study Study design Ethics approval BiobankFunding Patient categories Total number of patients to be includedAge of patientsCollaborative institutionsRegional health trust
1 Ongoing Olav DalgardAkershus UniversitetssykehusNorwegian coronavirus disease 2019 (NO COVID-19) study: An open labeled randomized controlled pragmatic trial evaluate the antiviral effect of chloroquine in adult patients with SARS-COV-2 infection Treatment Yes Hospitalized patients without intensive care200>18 years Helse Sør-Øst
2PlanningTormod FladbyAkershus Universitetssykehus HFControlling IFN responses for CoV Protection and adjuvant Treatment (CICPaT) – an adaptive, two-stage open label, pragmatic randomized controlled trial in hospitalized adults diagnosed with COVID-19TreatmentNoIntensive care patients/Hospitalized patients without intensive care150>18 yearsThe Norwegian Institute of Public Health University of OsloHelse Sør-Øst
3OngoingPål AukrustOslo UniversitetssykehusWHO: The NOR Solidarity multicenter trial on the efficacy of different anti-viral drugs in SARS CoV-2 infected patients

ClinicalTrials.gov
TreatmentYesYesIntensive care patientsInternational multicenter studyHelse Sør-Øst
4OngoingLise Sofie Nissen-MeyerOslo UniversitetssykehusOpen randomized controlled phase 2 clinical trial for evaluation of safety and efficacy of COVID-19 convalescent plasma compared to standard care for treatment of COVID-19 disease among elderlyTreatmentNoYesInpatients other institutionsApprox 500>50National multicenter study including blood banks, nursery homes and COVID-19-dedicated primary care institutions in several health regions.Helse Sør-Øst
5OngoingHanne ScholzOslo UniversitetssykehusPlacenta-derived Decidual stromal cells (DSC) in the treatment of acute pulmonary diseaseTreatmentNoYesHospitalized patients without intensive careHelse Sør-Øst
6OngoingFridtjof HeyerdahlOslo UniversitetssykehusInhaled NO as bridge to rapid sequence intubation in COVID-19 related hypoxemia (INOCOV-19)TreatmentNoNoHospitalized patients without intensive careHelse Sør-Øst
7PlanningJon Henrik LaakeOslo UniversitetssykehusHandling oxygenation targets in adults with COVID-19 associated acute hypoxaemic respiratory failure in the ICUTreatmentYesNoHelse Sør-Øst
8OngoingAnders ÅsbergOslo UniversitetssykehusPharmacokinetic population analysis of antiviral drugs in the NOR SOLIDARITY studyTreatmentYesHelse Sør-Øst

Study design: Observational

NrProject status Project leader/Contact info
Health trust/InstitutionStudy title/Aims of the study Study design Ethics approval BiobankFunding Patient categories Total number of patients to be includedAge of patientsCollaborative institutionsRegional health trust
1OngoingJørgen DahlbergAkershus UniversitetssykehusICU triageObservationalYes Intensive care patientsApprox 90All patients assessed for intensive care treatmentOslo University HospitalHelse Sør-Øst
2PlanningJonn Terje GeitungAkershus UniversitetssykehusRadiology of Covid patientsObservationalNoIntensive care patients/Hospitalized patients without intensive care/Outpatients1-550-100Helse Sør-Øst
3Ongoing Christopher InchleyAkershus UniversitetssykehusCOVID-19 in hospitalised Norwegian children – risk factors, outcomes and immunologyObservational Yes YesIntensive care patients/Hospitalized patients without intensive care/Outpatients250≤ 18 yearsUniversity Hospital of North Norway; St Olavs Hospital; Oslo University Hospital; Stavanger University Hospital; Østfold Hospital; Vestre Viken Hospital; Fonna Health (Haugesund Hospital); Haukeland University Hospital, Bergen; Health Møre and Romsdal (Ålesund Hospital); Innlandet Hospital (Lillehammer); Nordland Hospital (Bodø); Norwegian Institute of Public HealthHelse Sør-Øst
4OngoingTorbjørn OmlandAkershus UniversitetssykehusMekanismer bak sykelighet og dødelighet ved COVID-19

ClinicalTrials.gov
ObservationalYesIntensive care patients/Hospitalized patients without intensive care200>18 yearsHelse Sør-Øst
5OngoingTorbjørn OmlandAkershus UniversitetssykehusUse of blood pressure medication and risk of COVID-19 infection and complicationsObservationalYesNoHelse Sør-Øst
6OngoingGunnar EinvikAkershus UniversitetssykehusPatient reported outcomes and lung function after hospitalization for COVID-19 infection (PROLIFE)ObservationalYesNoIntensive care patients/Hospitalized patients without intensive care500>18Akershus University Hospital, University of Oslo, Landsforeningen for Hjerte- og lungesyke, Oslo Universitetssykehus (OUS), Sykehuset Østfold Kalnes (SØ), Haukeland universitetssykehus (HUS), St. Olavs HospitalHelse Sør-Øst
7PlanningAnne EskildAkershus UniversitetssykehusThe SARS Cov-2 epidemic among pregnant women and pregnancy outcomesObservationalNoOutpatients50 00030Departments of Microbiology in NorwayHelse Sør-Øst
8OngoingTormod FladbyAkershus universitetssykehus HFControlling IFN responses for CoV Protection and adjuvant Treatment (CICPaT)ObservationalYesIntensive care patients/Hospitalized patients without intensive care200>18 yearsThe Norwegian Institute of Public Health University of OsloHelse Sør-Øst
9OngoingSilje Bakken JørgensenAkershus universitetssykehusCovid-19 infections in health care workers with different levels of exposure to SARS-CoV-2 infected patients (COVPROTECT)ObservationalYesYesNoOutpatients400adultsHelse Sør-Øst
10PlanningGrethe Åstrøm UelandBergen/Noklus/Norwegian diabetesregistry for AdultsPatient reported outcome measures (PROMS) in patients with diabetes mellitus type I og II under the Covid-19 pandemic 2020ObservationalYesIntensive care patients/Hospitalized patients without intensive care/Outpatients10 000 with type 1 diabetes and 19 000 with type 2 diabetes18 – 100 årThe Norwegian diabetes registry for adults collects data from all health regions in NorwayHelse Vest
11Ongoing Marius MyrstadBærum sykehus Vestre Viken HFCovid-19 at BæRum hospital – Acute care and outcomes (The COBRA-study)Observational No Intensive care patients/Hospitalized patients without intensive careAll patients admitted to hospital with covid-1918 years and olderHelse Sør-Øst
12OngoingHans FlaattenHaukeland UniversitetssjukehusPrognostic factors in criticall ill patients with COVID-19 infection ≥ 70 years. A multicenter international study: COVIP

ClinicalTrials.gov
ObservationalYesNoIntensive care patients>1000≥7010 hospitals in Norway, including all region hospitals. More than 100 ICUs throughout Europe & IsraelHelse Vest
13OngoingHilde EngjomHaukeland UniversitetssjukehusCOVID19 in pregnancy- NorwayObservationalYesNoIntensive care patients/Hospitalized patients without intensive care/OutpatientsNational Advisory Unit for Womens’s Health and the Norwegian Institute of Public HealthHelse Vest
14OngoingRebecca CoxHaukeland UniversitetssjukehusCOVID-19 infection in the general population and health care workersObservationalYesIntensive care patients/Hospitalized patients without intensive care/Outpatients/Inpatients other institutions25000-100Haukeland University Hospital, University in Bergen, Haraldsplass Hospital, Bergen Kommune, Stavanger University HospitalHelse Vest
15OngoingCecilie SvanesHaukeland Universitetssjukehus/ Universitetet i BergenSusceptible to Covid-19ObservationalNoOutpatients200about 20-70 yearsHaukeland Universityhospital and University of BergenHelse Vest
16OngoingEystein HusebyeHelse BergenObservational study of Covid-19 infections in patients with primary adrenal insufficiencyObservationalYesNoOutpatients10018 and aboveAll somatic hospitals in NorwayHelse Vest
17OngoingOddbjørn HoveHelse Fonna HFTeleconsultation for adults with developmental disabilitiesObservationalNoOutpatients5018+Helse Vest
18OngoingKjetil SøreideHelse StavangerCovidSurg

ClinicalTrials.gov
ObservationalYesNoIntensive care patients/Hospitalized patients without intensive care2500?>18 yearsGlobal, international, currently >150 countriesHelse Vest
19OngoingLise Tuset GustadNord-Trøndelag HFClinical characterization of Coronavirus disease (COVID-19) and long-term consequences on individual and communitiesObservationalYesIntensive care patients1200>18HNT HF, NTNU, SINTEF, Helse Bergen, University of MichiganHelse Midt-Norge
20OngoingArne Vasli SøraasOslo UniversitetssykehusRisk factors for community- and workplace transmission of COVID-19

ClinicalTrials.gov
ObservationalYesNoHelse Sør-Øst
21OngoingKristin HofsøOslo UniversitetssykehusSurvival rates and long-term outcomes for patients with COVID-19 admitted to Norwegian ICUsObservationalNoNoYesIntensive care patientsHelse Sør-Øst
22OngoingMette KalagerOslo UniversitetssykehusCOVID-19 Public Response and Rapid-Cycle Re-Implementation of ActivitiesObservationalYesNoHelse Sør-Øst
23OngoingKjetil SundeOslo UniversitetssykehusIntensive medicine priority decisions during the COVID-19 pandemic (INTENSIVE TRIAGE)ObservationalYesNoIntensive care patientsHelse Sør-Øst
24OngoingLars WikOslo UniversitetssykehusUse of self-report and sensors for monitoring clinical parameters during home isolation of patients with COVID-19 infectionObservationalNoNoOutpatientsHelse Sør-Øst
25OngoingTine GrimholtOslo UniversitetssykehusThe aims are to study a representative sample of Norwegian people, their quality of life, stress and coping strategies during the first phase of the corona outbreak in NorwayObservationalYesNoHelse Sør-Øst
26OngoingTine GrimholtOslo UniversitetssykehusMental reactions to COVID-19 among adults with heart failureObservationalYesNoIntensive care patients|Hospitalized patients without intensive care|Outpatients|Inpatients other institutions2000AdultsHelse Sør-Øst
27PlanningLene Bergendal SolbergOslo UniversitetssykehusLongitudinal population-based environmental seroepidemiological investigation protocol for COVID-19 virus infection in healthcare workers in an orthopeadic emergency departmentObservationalNoYesHelse Sør-Øst
28OngoingElfrida Hartveit KvarsteinOslo UniversitetssykehusVulnerable patients with personality disorder – consequences of the corona crisisObservationalYesNoHospitalized patients without intensive careHelse Sør-Øst
29OngoingJan Cato HolterOslo Universitetssykehus HFNorwegian SARS-CoV-2 study

ClinicalTrials.gov
ObservationalYesYesIntensive care patients/Hospitalized patients without intensive care1000 or more18 years and older8 hospitals in Norway, including all region hospitals, taking part in ISARIC COVID-19 Global data collaborativeHelse Sør-Øst
30OngoingMaria Stylianou KorsnesOslo UniversitetssykehusCOVID-19 impact on patient careObservationalNoNoHelse Sør-Øst
31FinalisedPeter Monrad-HansenOslo UniversitetssykehusAppendicitis presentation and treatment before and after COVID-19; business as usual, or delay?ObservationalNoNoHelse Sør-Øst
32OngoingKristian TonbyOslo UniversitetssykehusCOVID-19 OUS. Kvalitetsregister for alle pasienter innlagt ved Oslo Universitetssykehus med COVID-19 sykdomObservationalNoNoHelse Sør-Øst
33OngoingMargrethe von TangenOslo UniversitetssykehusRetrospektiv vurdering av triagering av Covid-19 pasienter ved bruk av nytt Kap 41: Mistanke om Corona-infeksjonObservationalNoNoHelse Sør-Øst
34PlanningTrond H. DisethOslo UniversitetssykehusHow to prevent social isolation and psychosocial dysfunction in the general child population and in children with chronic/severe somatic diseases facing the COVID-19 pandemicObservationalNoNoHelse Sør-Øst
35PlanningSøren PischkeOslo UniversitetssykehusPrevalence of complement activation in COVID-19 patients admitted to OUSObservationalNoNoHelse Sør-Øst
36OngoingKristin BjordalOslo UniversitetssykehusDevelopment of an international questionnaire to assess patient-reported symptoms and concerns related to COVID-19 disease, the COVID-19 QLQ-##ObservationalNoNoHelse Sør-Øst
37OngoingStig EvensenOslo UniversitetssykehusCOPSYC-19: Consequences for patients with psychosis from the SARS-CoV-2 shut-downObservationalYesNoHelse Sør-Øst
38OngoingJostein Skjalg HagemoOslo UniversitetssykehusPrehospital treatment of «silent hypoxia» in young patients COVID-19ObservationalNoNoHelse Sør-Øst
39OngoingErik Koldberg AmundsenOslo UniversitetssykehusLaboratory diagnostics for risk stratification in COVID-19ObservationalYesYesHelse Sør-Øst
40OngoingÅslaug HellandOslo UniversitetssykehusSARS-CoV-2 and CancerObservationalYesNoHelse Sør-Øst
41OngoingIrene LieOslo UniversitetssykehusA Norwegian study on views and experiences of health care professions working in intensive care units during the COVID-19 pandemicObservationalNoHelse Sør-Øst
42PlanningSuraj Bahadur ThapaOslo UniversitetssykehusPsychological distress and Coping in Psychiatric Patients during COVID-19 pandemic (PsyCo-COVID-19): A cross-sectional study at Oslo University HospitalObservationalNoNoHelse Sør-Øst
43PlanningArne Eltvedt FianeOslo UniversitetssykehusEuroECMO-COVIDObservationalNoNoHelse Sør-Øst
44OngoingAnn FærdenOslo Universitetssykehus HFThe COVID-19 pandemic: Reactions from of acutely ill psychiatric patientsObservationalNoNoYesHospitalized patients without intensive care50Helse Sør-Øst
45OngoingAnn FærdenOslo Universitetssykehus HFThe COVID-19 pandemic: Reactions from mental health workers in the acute psychiatric departmentObservationalNoNoYes300Helse Sør-Øst
46OngoingLudvig MuntheOslo Universitetssykehus HFDefining the immune cells that correlate with fatal acute lung injury in COVID-19ObservationalNoYesHelse Sør-Øst
47OngoingHilde WøienOslo Universitetssykehus HFDelirium in critically ill patients with SARS-CoV-2 infectionObservationalNoNoIntensive care patients1000Helse Sør-Øst
48OngoingKristin Lie RommOslo Universitetssykehus HFCOPE – Corona pandemic experiences by patients with psychotic – and bipolar disordersObservationalYesNoYesHospitalized patients without intensive care|Outpatients300Helse Sør-Øst
49OngoingAnn Lee SolevågOslo Universitetssykehus HFVisitor bans in hospitals: How are newborn infants affected during the COVID-19 pandemic?ObservationalNoYesNoIntensive care patients|Hospitalized patients without intensive care300InfantsHelse Sør-Øst
50OngoingOliver Distler

Local contact OUS:
Anna Hoffmann-Vold
Zürich University hospital, SwitzerlandCOVID-19 in the EUSTAR cohort of systemic sclerosisObservationalNoNoHelse Sør-Øst
51OngoingGrete Dyb

Local contact OUS:
John-Anker Zwart
Norwegian Center for Violence and Traumatic Stress Studies, Universitetet i OsloStress responses and health complaints among hospital staff working in intensive care units and clinical wards during the COVID-19 pandemicObservationalNoNoHelse Sør-Øst
52PlanningMargrethe Greve-Isdahl

Local contact OUS:
Per Kristian Knudsen
Norwegian Institute of Public Health, OsloMINI-Nor Maternal and Infant Immunity against Vaccine Preventable Diseases in NorwayObservationalNoNoHelse Sør-Øst
53OngoingLocal contact OUS:
Geir E. Tjønnfjord
Memorial Sloan Kettering Cancer Center, New YorkExamining COVID19 Course and Outcomes in Patients Previously Diagnosed with Chronic Lymphocytic LeukemiaObservationalNoNoHelse Sør-Øst
54OngoingErik SolligårdSt.Olavs hospitalCUT COVID-19 Coronaundersøkelsen Trøndelag – Risk stratification of severe COVID-19 infection in children and adultsObservationalYesIntensive care patients/Hospitalized patients without intensive care20000-100 yearsHelse Nord-Trøndelag, Helse Møre og Romsdal, NTNU, UNNHelse Midt-Norge
55PlanningLine PedersenSt.Olavs and Sørlandet HospitalHome monitoring and followup og COVID-19 patientsObservationalNoHospitalized patients without intensive care/Outpatients200From 18 and up.St.Olavs Hospital and Sørlandet HospitalHelse Midt-Norge
56PlanningTorbjørn Moe EggebøStavanger universitetssjukehusCovid-19 infection in pregnancyObservationalNoOutpatients400018-50Helse Vest
57OngoingIngvil MjaalandStavanger universitetssjukehusKvalitetsoppfølging av pasienter med tidlig brystkreft som får endret fraksjonering i strålebehandling som følge av Covid-19 pandemien.ObservationalNoOutpatients30 patients, maybe more if the pandemic lasts longer18 years or olderHelse Vest
58OngoingChristine M. JonassenSykehuset ØstfoldViral factors associated with severe cases of COVID-19ObservationalNoIntensive care patients/Hospitalized patients without intensive care/Outpatients/Inpatients other institutions150>18Helse Sør-Øst
59PlanningGernot ErnstVestre Viken HF, Kongsberg sykehusLoss of olfaction as an early predictor for the development of critical COVID-19 infectionsObservationalNoOutpatients200>18Helse Sør-Øst
60PlanningGernot ErnstVestre Viken HF, Kongsberg sykehusHeart Rate Variability as prognostic factor in patients with COVID-19 infectionObservationalNoIntensive care patients/Hospitalized patients without intensive care60>18Helse Sør-Øst

Study design: Other

NrProject status Project leader/Contact info
Health trust/InstitutionStudy title/Aims of the study Study design Ethics approval BiobankFunding Patient categories Total number of patients to be includedAge of patientsCollaborative institutionsRegional health trust
1OngoingEspen Saxhaug KristoffersenAkershus universitetssykehus HFNeurology during the pandemic (NeuroPan)OtherNo100-150>18 yearsOslo University Hospital and Haukeland University HospitalHelse Sør-Øst
2OngoingEspen Saxhaug KristoffersenAkershus universitetssykehus HFStroke during a pandemic (StrokePan) studyOtherYesHospitalized patients without intensive care35017-100Helse Sør-Øst
3OngoingIngrid MiljeteigHelse BergenPriority dilemma, moral distress and support experienced by physicians and nurses in Helse Vest during the COVID-19-epidemicOtherYesUniversity of BergenHelse Vest
4PlanningHarleen GrewalHelse Bergen og Universitet i BergenCohort study of COVID-19 Nested within a Randomised Controlled Trial of Patients Hospitalised with Community Acquired Pneumonia: Disease severity, Optimised management, and OutcomesOtherYesHospitalized patients without intensive careUncertain, would depend upon the evolution of the epidemic.Adults ≥18 yearsCopenhagen University, Leiden University (Netherlands), University of Southampton (UK)Helse Vest
5PlanningMette TollånesUniversitetet i BergenProtokoll for utprøving av immunologiske hurtigtester for COVID-19OtherNoNoHelse Vest
6OngoingArne Broch BrantsæterOslo UniversitetssykehusSerum standard for COVID-19 vaccineOtherNoYesHelse Sør-Øst
7OngoingAnders ÅsbergOslo UniversitetssykehusCOVID-19 outcome in patients with chronic kidney diseaseOtherYesYesHospitalized patients without intensive careHelse Sør-Øst
8OngoingGunnveig GrødelandOslo UniversitetssykehusNovel vaccine development against COVID-19OtherYesNoHelse Sør-Øst
9OngoingTom MalaOslo UniversitetssykehusAbdominal pain in COVID-19 patientsOtherNoNoHospitalized patients without intensive careHelse Sør-Øst
10OngoingMarius RehnOslo UniversitetssykehusPre-hospital management of COVID-19OtherNoNoHospitalized patients without intensive careHelse Sør-Øst
11PlanningJørgen Vildershøj BjørnholtOslo UniversitetssykehusCOVID-19 and hydroxychloroquine chemoprophylaxis in healthcare workers – efficacy and safetyOtherNoNoHelse Sør-Øst
12OngoingTom Hemming KarlsenOslo UniversitetssykehusAn anonymized GWAS to urgently query host genetic predisposition to severe COVID-19 (SARS-CoV-2 infection) lung diseaseOtherNoYesHospitalized patients without intensive careHelse Sør-Øst
13PlanningArne KlunglandOslo UniversitetssykehusEpitranscriptomic regulation of viral fitness upon SARS-CoV-2 infection; a host-virus studyOtherNoNoHelse Sør-Øst
14PlanningStefan KraussOslo UniversitetssykehusPharmacological WNT inhibition to attenuate the cytokine storm, the central severe complication in COVID-19 infectionsOtherNoNoHelse Sør-Øst
15PlanningFridtjof Lund-JohansenOslo UniversitetssykehusCOVID-19 immunity in the populationOtherNoNoHelse Sør-Øst
16PlanningLudvig MuntheOslo UniversitetssykehusEstablishing in tube-diagnostic tests for immunity or susceptibility for SARS-CoV-2 in elderly cancer patients and in high-risk childrenOtherNoNoYesHelse Sør-Øst
17OngoingKarl ØyriOslo UniversitetssykehusResearch and Development for a low-cost, quickly produced mechanical ventilator capacity scaling system for Covid-19 affected communitiesOtherNoNoHelse Sør-Øst
18PlanningCharles Ethan PaccioneOslo UniversitetssykehusThe Mind-Body App for Mental Health ManagementOtherNoNoHelse Sør-Øst
19PlanningSimon RaynerOslo UniversitetssykehusIntegrated novel intervention strategies for COVID-19 : Using data mining to fight current and future pandemicsOtherNoNoHelse Sør-Øst
20PlanningTone TønjumOslo UniversitetssykehusReversing COVID-19 (RevCOVID-19)OtherNoNoHelse Sør-Øst
21OngoingAtle BjørnerudOslo UniversitetssykehusArtificial intelligence to quantify important segments from CT in COVID-19OtherNoHelse Sør-Øst
22OngoingHåvard KalvøyOslo UniversitetssykehusSplitting one ventilator for multiple patientsOtherNoHelse Sør-Øst
23OngoingKristin Lie RommOslo UniversitetssykehusREACT-NOR – react now!
Remote follow-up of relatives of patients with psychosis during the COVID-19 crisis
OtherNoNoHelse Sør-Øst
24OngoingLars EideOslo UniversitetssykehusCOVID-19 general biobankOtherYesYesHelse Sør-Øst
25PlanningKjetil TaskénOslo Universitetssykehus Immunoregulatory and antiviral properties of compounds derived from anti-malaria drugs as hydroxychloroquineOtherNoNoHelse Sør-Øst
26PlanningEivind HovigOslo UniversitetssykehusProduction of «in house» versions of reverse transcriptase and Taq DNA polymerase for use in SARS-CoV-2 assaysOtherNoNoYesHelse Sør-Øst
27PlanningLars LienSykehuset InnlandetThe impact of the coronavirus disease (COVID-19) outbreak on people with concurrent mental health and substance use disordersOtherNoOutpatients2518-65VID, HINNHelse Sør-Øst
28OngoingLars Petter BjørnsenSt.Olavs hospital Universitetssykehus TrondheimUltralydsdiagnostikk av mistenkt COVID-19 smittede pasienter i akuttmottaketOtherNoHospitalized patients without intensive care200Over 16 årSørlandet sykehus HF, St Olavs hospital, Haukeland Universitetssykehus, Oslo universitetssykehus Ullevål, Nordlandssykehuset HF Bodø, Drammen sykehus, Sykehuset Telemark HF Skien, Stavanger universitetssykehus, Akurshus universitetssykehusHelse Midt-Norge
29OngoingHege Selnes HaugdahlHelse Nord-Trøndelag HFIsolated and critically ill – experiences of video-communication between ICU family members and ICU nurses and physicians during the Covid-19 diseaseOtherNoNoNoIntensive care patients8-12 ICU family membersUiT The Arctic University of NorwayHelse Midt-Norge
30OngoingWaleed GhanimaSykehuset ØstfoldResearch biobank for internal medicineOtherYesIntensive care patients/Hospitalized patients without intensive care/OutpatientsHelse Sør-Øst